The Brighterside of News on MSN
AI breakthrough predicts how mRNA makes proteins inside the body
In the fast-evolving field of medical science, a new artificial intelligence model may be about to change the way mRNA-based ...
The Brighterside of News on MSN
UPenn researchers reinvent the way COVID-19, cancer, and genetic disorders are treated
Researchers have developed a new lipid for delivering mRNA that is safer and more effective than current technologies. By ...
Learn from the MHRA about evolving CMC expectations, submission criteria, and initiatives for streamlining approval routes for mRNA platforms. Continuous processing: Optimizing efficiency & ...
U.S. defense supports mRNA vaccine development as health department withdraws funding U.S. defense agency backs mRNA vaccine ...
The Brighterside of News on MSN
New mRNA vaccine shows promise for preventing blindness
Excessive blood vessel growth in the retina at the back of the eye is a primary driver of blindness in older individuals. The ...
STONY BROOK, NY / ACCESSWIRE / September 17, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced its participation at upcoming mRNA ...
Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a biotechnology company focused on providing nucleic acid production solutions for the biopharmaceutical and diagnostics ...
An mRNA vaccine developed by researchers from Japan suppressed abnormal blood vessel growth or neovascularization in the retina of mouse models. Neovascularization is a condition that is caused by age ...
LineaRx will present its Linea™ IVT platform - a combination of an enzymatically produced DNA template (Linea™ DNA IVT template) coupled with a next-generation RNA polymerase (Linea™ RNAP) - as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback